|
Variables
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
HR (95% CI)
|
P value
|
HR (95% CI)
|
P value
|
|---|
|
Age (years, mean ± SD)
|
0.989 (0.971–1.006)
|
1.937E−01
|
NA
|
NA
|
|
Gender (Male/Female)
|
1.630 (1.030–2.579)
|
3.521E−02*
|
1.567 (0.984–2.495)
|
5.872E−02
|
|
Pathologic M (M0/M1/−)
|
3.498 (2.015–6.072)
|
2.162E−06*
|
2.358 (0.870–6.391)
|
9.165E−02
|
|
Pathologic N (N0/N1/N2)
|
0.909 (0.537–1.540)
|
7.226E−01
|
NA
|
NA
|
|
Pathologic T (T1/T2/T3/T4)
|
2.310 (1.484–3.597)
|
3.167E−04*
|
1.552 (0.909–2.649)
|
1.070E−01
|
|
Pathologic stage (I/II/III/IV/−)
|
1.849 (1.423–2.402)
|
2.874E−06*
|
1.482 (1.105–1.986)
|
8.541E−03*
|
|
lncRNA RS model (High/Low)
|
2.925 (1.773–4.825)
|
1.062E−05*
|
2.438 (1.443–4.118)
|
8.610E−04*
|
|
Recurrence (Yes/No)
|
NA
|
NA
|
NA
|
NA
|
|
Recurrence free survival time (months, mean ± SD)
|
NA
|
NA
|
NA
|
NA
|
- *Statistically significant; RS risk score, HR hazard ratio, CI confidence interval, NA not analyzed
